AG真人官方

STOCK TITAN

[D] Cybin Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D
Rhea-AI Filing Summary

CYBIN INC. filed a Form D notice reporting a Regulation D exempt offering of options. The filing states a total potential offering amount of $637,404 USD (maximum proceeds from option exercises) and that $0 has been sold to date. The securities are stock options exercisable at CAD$11.00 per share that vest in eight quarterly tranches beginning September 30, 2025. The issuer selected Rule 506(b) as the exemption and indicated the offering may last more than one year. The Form D lists two investors in the offering, both non-accredited, and discloses no sales commissions or finders' fees and $0 proposed for payments to named executives or directors.

CYBIN INC. ha depositato un avviso Form D relativo a un'offerta esentata ai sensi del Regulation D per opzioni. Il documento indica un importo massimo potenziale dell'offerta pari a $637.404 USD (proventi massimi derivanti dall'esercizio delle opzioni) e che ad oggi non 猫 stata venduta alcuna quota. Le attivit脿 sono opzioni su azioni esercitabili a CAD$11,00 per azione che maturano in otto tranche trimestrali a partire dal 30 settembre 2025. L'emittente ha scelto come esenzione la Rule 506(b) e ha indicato che l'offerta potrebbe protrarsi oltre un anno. Il Form D elenca due investitori nell'offerta, entrambi non accreditati, e dichiara l'assenza di commissioni di vendita o compensi per finder e $0 destinati a pagamenti per dirigenti o amministratori nominati.

CYBIN INC. present贸 un aviso Form D informando una oferta exenta bajo el Regulation D de opciones. El expediente indica un importe potencial total de la oferta de $637,404 USD (ingresos m谩ximos por el ejercicio de las opciones) y que hasta la fecha no se ha vendido nada. Los valores son opciones sobre acciones ejercitables a CAD$11.00 por acci贸n que se consolidan en ocho tramos trimestrales a partir del 30 de septiembre de 2025. El emisor seleccion贸 la Regla 506(b) como exenci贸n y se帽al贸 que la oferta puede durar m谩s de un a帽o. El Form D enumera dos inversores en la oferta, ambos no acreditados, y revela ninguna comisi贸n de venta ni pago a intermediarios y $0 propuestos para pagos a ejecutivos o directores nombrados.

CYBIN INC.電� 鞓奠厴鞐� 雽頃� Regulation D 氅挫牅 鞝滉车鞚� 鞁犼碃頃橂姅 Form D 韱奠靹滊ゼ 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 鞓奠厴 頄夓偓搿� 鞚疙暅 斓滊寑 鞛犾灛 氇旮堨暋鞚� $637,404 USD鞚搓碃 順勳灛旯岇 毵れ稖鞚 鞝勴榾 氚滌儩頃橃 鞎婌晿雼�瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 歃濌秾鞚 欤茧嫻 CAD$11.00鞐� 頄夓偓頃� 靾� 鞛堧姅 鞀ろ啞鞓奠厴鞙茧, 2025雲� 9鞗� 30鞚�攵韯� 鞁滌瀾頃橃棳 8須� 攵勱赴氤勲 氩犾姢韺呺惄雼堧嫟. 氚滍枆鞚胳潃 氅挫牅搿� Rule 506(b)毳� 靹犿儩頄堨溂氅� 頃措嫻 鞝滉车鞚� 1雲� 鞚挫儊 歆靻嶋悹 靾� 鞛堨潓鞚� 響滌嫓頄堨姷雼堧嫟. Form D鞐愲姅 霊� 氇呾潣 韴瀽鞛愱皜 旮办灛霅橃柎 鞛堨溂氅� 霊� 雼� 牍勳澑歃� 韴瀽鞛�(牍�-accredited)鞚搓碃, 韺愲Г 靾橃垬耄岆倶 敫岆旎� 靾橃垬耄岆姅 鞐嗢溂氅� 歆氇呺悳 鞛勳洂 霕愲姅 鞚挫偓鞐愱矊 歆旮夒悹 鞓堨爼鞎§潃 $0搿� 瓿店皽霅橃棃鞀惦媹雼�.

CYBIN INC. a d茅pos茅 un avis Form D signalant une offre exon茅r茅e en vertu du Regulation D pour des options. le d茅p么t indique un montant potentiel total de l'offre de $637,404 USD (produits maximums provenant de l'exercice des options) et que rien n'a 茅t茅 vendu 脿 ce jour. Les titres sont des options d'achat d'actions exer莽ables 脿 CAD$11.00 par action qui acqui猫rent des droits en huit tranches trimestrielles 脿 partir du 30 septembre 2025. L'茅metteur a choisi la Rule 506(b) comme exemption et a indiqu茅 que l'offre pourrait durer plus d'un an. Le Form D r茅pertorie deux investisseurs dans l'offre, tous deux non accr茅dit茅s, et d茅voile aucune commission de vente ni frais d'interm茅diaire et $0 pr茅vus pour des paiements aux dirigeants ou administrateurs nomm茅s.

CYBIN INC. hat eine Form D-Meldung eingereicht, die ein nach Regulation D befreites Angebot von Optionen meldet. Die Einreichung nennt einen m枚glichen Gesamtangebotsbetrag von $637.404 USD (maximale Erl枚se aus Aus眉bung der Optionen) und dass bisher nichts verkauft wurde. Die Wertpapiere sind Aktienoptionen, aus眉bbar zu CAD$11,00 je Aktie, die in acht viertelj盲hrlichen Tranchen ab dem 30. September 2025 verfallen/vesten. Der Emittent w盲hlte Rule 506(b) als Ausnahmeregelung und gab an, dass das Angebot mehr als ein Jahr dauern kann. Das Form D listet zwei Investoren in dem Angebot auf, beide nicht akkreditiert, und gibt an, dass es keine Verkaufsprovisionen oder Findergeb眉hren gibt und $0 f眉r Zahlungen an benannte Gesch盲ftsf眉hrer oder Direktoren vorgesehen sind.

Positive
  • Clear option terms disclosed: exercise price (CAD$11.00) and vesting schedule (eight quarterly tranches beginning September 30, 2025) are stated
  • Regulation D exemption chosen (Rule 506(b)), a commonly relied-upon legal basis for private offerings
  • No sales commissions or finders' fees reported and $0 disclosed for payments to executives/directors
Negative
  • No proceeds received yet: Total amount sold is reported as $0
  • Small maximum offering size: Total potential proceeds of $637,404 USD are modest
  • Includes non-accredited investors: Two non-accredited investors are reported, which may impose additional disclosure or resale considerations

Insights

TL;DR: Routine Form D filing for employee/option-related issuance; small maximum proceeds and no sales yet.

The filing documents a Regulation D Rule 506(b) exempt offering comprised of stock options exercisable at CAD$11.00 with scheduled vesting beginning September 30, 2025. The maximum potential proceeds from exercise are listed as $637,404 USD, with no amounts sold to date. Two investors are reported and both are non-accredited. No placement agents, commissions, or payments to insiders are disclosed. This appears to be a corporate compensation-related issuance rather than a capital-raising public offering.

TL;DR: Governance disclosure is straightforward: executives and directors are listed; no insider payments disclosed.

The Form D identifies multiple officers and directors by name and address and shows the CFO signed the notice. It specifies that proceeds used for payments to named officers or directors are $0. The filing duration is expected to exceed one year and the structure (options with staged vesting) aligns with employee compensation practices. The disclosure of two non-accredited investors is notable but the filing includes no material deviations from standard Reg D practice.

CYBIN INC. ha depositato un avviso Form D relativo a un'offerta esentata ai sensi del Regulation D per opzioni. Il documento indica un importo massimo potenziale dell'offerta pari a $637.404 USD (proventi massimi derivanti dall'esercizio delle opzioni) e che ad oggi non 猫 stata venduta alcuna quota. Le attivit脿 sono opzioni su azioni esercitabili a CAD$11,00 per azione che maturano in otto tranche trimestrali a partire dal 30 settembre 2025. L'emittente ha scelto come esenzione la Rule 506(b) e ha indicato che l'offerta potrebbe protrarsi oltre un anno. Il Form D elenca due investitori nell'offerta, entrambi non accreditati, e dichiara l'assenza di commissioni di vendita o compensi per finder e $0 destinati a pagamenti per dirigenti o amministratori nominati.

CYBIN INC. present贸 un aviso Form D informando una oferta exenta bajo el Regulation D de opciones. El expediente indica un importe potencial total de la oferta de $637,404 USD (ingresos m谩ximos por el ejercicio de las opciones) y que hasta la fecha no se ha vendido nada. Los valores son opciones sobre acciones ejercitables a CAD$11.00 por acci贸n que se consolidan en ocho tramos trimestrales a partir del 30 de septiembre de 2025. El emisor seleccion贸 la Regla 506(b) como exenci贸n y se帽al贸 que la oferta puede durar m谩s de un a帽o. El Form D enumera dos inversores en la oferta, ambos no acreditados, y revela ninguna comisi贸n de venta ni pago a intermediarios y $0 propuestos para pagos a ejecutivos o directores nombrados.

CYBIN INC.電� 鞓奠厴鞐� 雽頃� Regulation D 氅挫牅 鞝滉车鞚� 鞁犼碃頃橂姅 Form D 韱奠靹滊ゼ 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 鞓奠厴 頄夓偓搿� 鞚疙暅 斓滊寑 鞛犾灛 氇旮堨暋鞚� $637,404 USD鞚搓碃 順勳灛旯岇 毵れ稖鞚 鞝勴榾 氚滌儩頃橃 鞎婌晿雼�瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 歃濌秾鞚 欤茧嫻 CAD$11.00鞐� 頄夓偓頃� 靾� 鞛堧姅 鞀ろ啞鞓奠厴鞙茧, 2025雲� 9鞗� 30鞚�攵韯� 鞁滌瀾頃橃棳 8須� 攵勱赴氤勲 氩犾姢韺呺惄雼堧嫟. 氚滍枆鞚胳潃 氅挫牅搿� Rule 506(b)毳� 靹犿儩頄堨溂氅� 頃措嫻 鞝滉车鞚� 1雲� 鞚挫儊 歆靻嶋悹 靾� 鞛堨潓鞚� 響滌嫓頄堨姷雼堧嫟. Form D鞐愲姅 霊� 氇呾潣 韴瀽鞛愱皜 旮办灛霅橃柎 鞛堨溂氅� 霊� 雼� 牍勳澑歃� 韴瀽鞛�(牍�-accredited)鞚搓碃, 韺愲Г 靾橃垬耄岆倶 敫岆旎� 靾橃垬耄岆姅 鞐嗢溂氅� 歆氇呺悳 鞛勳洂 霕愲姅 鞚挫偓鞐愱矊 歆旮夒悹 鞓堨爼鞎§潃 $0搿� 瓿店皽霅橃棃鞀惦媹雼�.

CYBIN INC. a d茅pos茅 un avis Form D signalant une offre exon茅r茅e en vertu du Regulation D pour des options. le d茅p么t indique un montant potentiel total de l'offre de $637,404 USD (produits maximums provenant de l'exercice des options) et que rien n'a 茅t茅 vendu 脿 ce jour. Les titres sont des options d'achat d'actions exer莽ables 脿 CAD$11.00 par action qui acqui猫rent des droits en huit tranches trimestrielles 脿 partir du 30 septembre 2025. L'茅metteur a choisi la Rule 506(b) comme exemption et a indiqu茅 que l'offre pourrait durer plus d'un an. Le Form D r茅pertorie deux investisseurs dans l'offre, tous deux non accr茅dit茅s, et d茅voile aucune commission de vente ni frais d'interm茅diaire et $0 pr茅vus pour des paiements aux dirigeants ou administrateurs nomm茅s.

CYBIN INC. hat eine Form D-Meldung eingereicht, die ein nach Regulation D befreites Angebot von Optionen meldet. Die Einreichung nennt einen m枚glichen Gesamtangebotsbetrag von $637.404 USD (maximale Erl枚se aus Aus眉bung der Optionen) und dass bisher nichts verkauft wurde. Die Wertpapiere sind Aktienoptionen, aus眉bbar zu CAD$11,00 je Aktie, die in acht viertelj盲hrlichen Tranchen ab dem 30. September 2025 verfallen/vesten. Der Emittent w盲hlte Rule 506(b) als Ausnahmeregelung und gab an, dass das Angebot mehr als ein Jahr dauern kann. Das Form D listet zwei Investoren in dem Angebot auf, beide nicht akkreditiert, und gibt an, dass es keine Verkaufsprovisionen oder Findergeb眉hren gibt und $0 f眉r Zahlungen an benannte Gesch盲ftsf眉hrer oder Direktoren vorgesehen sind.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
X None
Entity Type
0001833141
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
CYBIN INC.
Jurisdiction of Incorporation/Organization
ONTARIO, CANADA
Year of Incorporation/Organization
X Over Five Years Ago
Within Last Five Years (Specify Year)
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
CYBIN INC.
Street Address 1 Street Address 2
100 King St. West, Suite 5600
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
Toronto ONTARIO, CANADA M5X 1C9 (866) 292-4601

3. Related Persons

Last Name First Name Middle Name
Drysdale Douglas
Street Address 1 Street Address 2
100 King St. West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Tziras George
Street Address 1 Street Address 2
100 King Street West Suite 560
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA V5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
So Eric
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Fahel Gabriel
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Glavine Paul
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Cavers Greg
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Bartlone Aaron
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Firestone Theresa
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Lawson Mark
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Froese Grant
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Hoskins Eric
Street Address 1 Street Address 2
100 King Street West Suite 5600
City State/Province/Country ZIP/PostalCode
Toronto ONTARIO, CANADA M5X 1C9
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
AG真人官方 Estate
Commercial
Construction
REITS & Finance
Residential
Other AG真人官方 Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
X
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-08-15 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
X Yes No

9. Type(s) of Securities Offered (select all that apply)

Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security X Other (describe)
Stock options exercisable at CAD$11.00 per share vesting in eight quarterly tranches beginning September 30, 2025.

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number X None
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
Street Address 1 Street Address 2
City State/Province/Country ZIP/Postal Code
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
Foreign/non-US

13. Offering and Sales Amounts

Total Offering Amount $637,404 USD
or Indefinite
Total Amount Sold $0 USD
Total Remaining to be Sold $637,404 USD
or Indefinite

Clarification of Response (if Necessary):

Total offering amount represents maximum potential proceeds from exercise of options. CAD$1.3806=USD$1.00

14. Investors

X
Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
2
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
2

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $0 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
CYBIN INC. /s/ Greg Cavers Greg Cavers CFO 2025-08-26

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


FAQ

What does CYBIN (CYBN) disclose in this Form D filing?

CYBIN reports a Rule 506(b) exempt offering of stock options with a maximum potential amount of $637,404 USD, $0 sold, and two investors.

What are the option exercise terms in the CYBIN Form D?

Options exercisable at CAD$11.00 per share vesting in eight quarterly tranches starting September 30, 2025.

Has CYBIN received any proceeds from this offering?

No. The Form D reports $0 total amount sold and $637,404 remaining to be sold.

Are there any sales commissions or finder鈥檚 fees disclosed by CYBIN?

No. The filing reports $0 for sales commissions and finders' fees.

Does the CYBIN offering include non-accredited investors?

Yes. The Form D lists 2 non-accredited investors and a total of 2 investors.
Cybin Inc

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Latest SEC Filings

CYBN Stock Data

141.07M
14.86M
105.29%
41.11%
10.94%
Biotechnology
Healthcare
Canada
Toronto